News

News

Science Exchange Collaborates with Renovo Neural to Offer Novel Neurological Research Services

September 6, 2018 – PALO ALTO, Calif.–(BUSINESS WIRE) — Science Exchange, the leading marketplace for outsourced R&D™, announced today a collaboration with Renovo Neural, a Contract Research Organization (CRO) specializing in degenerative neurological conditions.

Renovo has a history in model development for multiple sclerosis (MS) and recently expanded its efforts to offer other non-clinical research services such as immunohistochemistry and 3-D electron microscopy for a wide range of neurological disorders, including Parkinson’s Disease, Alzheimer’s Disease, and Charcot-Marie-Tooth Syndrome. Renovo is best known for having developed an augmented cuprizone model of MS. This model – developed by the pioneering work of Bruce Trapp and Wendy Macklin – has been documented to provide superior reliability in evaluating the remyelination potential of novel therapeutic candidate compounds. Renovo has an experienced team and proven capabilities to support research and development in neurology.

“While Renovo is already well-known in the field, collaborating with Science Exchange will help expand our reach to researchers who can benefit from the technical expertise our team can provide,” stated Vivek Shenoy, CEO of Renovo. “We will be in a better position to support R&D teams actively involved in the discovery of new therapies to treat or even reverse the debilitating effects of MS and other neurodegenerative diseases.”

“We are very excited to collaborate with Renovo Neural to make available its novel neurological research services readily available to scientists worldwide,” said Elizabeth Iorns, Ph.D., co-founder and CEO of Science Exchange. “Science Exchange is committed to adding the most innovative and qualified service providers to our platform, so scientists have secure, rapid access to the services they need to aid their discoveries. Renovo Neural has impressed us with their progress in the field of neurodegenerative diseases.

 

About Renovo Neural

Renovo Neural, Inc. is a private CRO operating in Cleveland, Ohio, for the past 10 years. The company was co-founded by Dr. Wendy Macklin and Dr. Bruce Trapp, Chief Scientific Officer of Renovo and the current chair of the Neuroscience Department at the Lerner Research Institute at the Cleveland Clinic. Drs. Macklin and Trapp are both recognized as world-renowned experts in Multiple Sclerosis research. The company offers pre-clinical / non-clinical translational research services with a focus on the evaluation of neuro-therapeutics.

ABOUT THE AUTHOR
author

Gursatya "Guru" Singh

Director of Scientific Content & Marketing

Gursatya Singh, also known as "Guru", manages the development and execution of strategic marketing initiatives to improve platform providers’ visibility and user experience. He is a true guru when it comes to helping providers better advertise their research services and providing buyers with easy access to recently commercialized external innovations. Whether working as a lab researcher, publishing scientific papers, or helping start life science startups, Guru believes in making the scientific world more collaborative and connected. Guru holds a master’s degree in biotechnology from the University of Delaware. Follow him on Twitter @Gursatya.

Leave a Reply

Your email address will not be published.